Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of fixed-dose dapagliflozin + metformin XR combinations in healthy Thai subjects (fasting)
TCTR20250228004Phase 1Completed
- Sponsor
- Sun Pharma
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of dapagliflozin + metformin, dapagliflozin and metformin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sun Pharma. Started Sep 2025; status: completed.
02
Drugs
dapagliflozin + metformindapagliflozinmetformin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20250228004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250228004.